Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

An intervention program for ADHD in patients with substance use disorders: preliminary results of a field trial.

Goossensen MA, van de Glind G, Carpentier PJ, Wijsen RM, van Duin D, Kooij JJ.

J Subst Abuse Treat. 2006 Apr;30(3):253-9.

PMID:
16616170
[PubMed - indexed for MEDLINE]
2.

Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.

Schubiner H.

CNS Drugs. 2005;19(8):643-55. Review.

PMID:
16097847
[PubMed - indexed for MEDLINE]
3.

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.

Wilens TE.

Psychiatr Clin North Am. 2004 Jun;27(2):283-301. Review.

PMID:
15063998
[PubMed - indexed for MEDLINE]
4.

[Comorbidity of substance use disorders and attention-deficit hyperactivity disorders: pathogenesis and therapy].

Fallgatter AJ, Jacob CP.

Nervenarzt. 2009 Sep;80(9):1015-21. doi: 10.1007/s00115-009-2742-0. Review. German.

PMID:
19672572
[PubMed - indexed for MEDLINE]
5.

Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).

Rösler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256 Suppl 1:i3-11. Review. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2008 Apr;258(3):192-3.

PMID:
16977549
[PubMed - indexed for MEDLINE]
6.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
[PubMed - indexed for MEDLINE]
7.

Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.

Adler LA, Guida F, Irons S, Rotrosen J, O'Donnell K.

Postgrad Med. 2009 Sep;121(5):7-10. doi: 10.3810/pgm.2009.09.2047.

PMID:
19820269
[PubMed - indexed for MEDLINE]
8.

Impact of substance use disorder on ADHD and its treatment.

Wilens TE, Upadhyaya HP.

J Clin Psychiatry. 2007 Aug;68(8):e20. Review.

PMID:
17876905
[PubMed - indexed for MEDLINE]
9.

The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?

Wilens TE, Monuteaux MC, Snyder LE, Moore H, Whitley J, Gignac M.

J Child Adolesc Psychopharmacol. 2005 Oct;15(5):787-98.

PMID:
16262595
[PubMed - indexed for MEDLINE]
10.

Screening and diagnostic utility of self-report attention deficit hyperactivity disorder scales in adults.

McCann BS, Roy-Byrne P.

Compr Psychiatry. 2004 May-Jun;45(3):175-83.

PMID:
15124147
[PubMed - indexed for MEDLINE]
11.

Adult ADHD and substance abuse: diagnostic and treatment issues.

Kalbag AS, Levin FR.

Subst Use Misuse. 2005;40(13-14):1955-81, 2043-8. Review.

PMID:
16282088
[PubMed - indexed for MEDLINE]
12.

Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD).

Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M.

Eur Arch Psychiatry Clin Neurosci. 2007 Oct;257(7):371-7.

PMID:
17902010
[PubMed - indexed for MEDLINE]
13.

Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.

Sentissi O, Navarro JC, De Oliveira H, Gourion D, Bourdel MC, Baylé FJ, Olié JP, Poirier MF.

Psychiatry Res. 2008 Oct 30;161(1):36-42. doi: 10.1016/j.psychres.2007.06.016. Epub 2008 Sep 10.

PMID:
18786727
[PubMed - indexed for MEDLINE]
14.

Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.

Upadhyaya HP.

J Clin Psychiatry. 2007;68 Suppl 11:23-30. Review.

PMID:
18307378
[PubMed - indexed for MEDLINE]
15.

The role of comorbid major depressive disorder in the clinical presentation of adult ADHD.

Fischer AG, Bau CH, Grevet EH, Salgado CA, Victor MM, Kalil KL, Sousa NO, Garcia CR, Belmonte-de-Abreu P.

J Psychiatr Res. 2007 Dec;41(12):991-6. Epub 2006 Nov 13.

PMID:
17098256
[PubMed - indexed for MEDLINE]
16.

The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.

Fatseas M, Debrabant R, Auriacombe M.

Curr Opin Psychiatry. 2012 May;25(3):219-25. doi: 10.1097/YCO.0b013e3283523d7c. Review.

PMID:
22449768
[PubMed - indexed for MEDLINE]
17.

A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting.

Culpepper L, Mattingly G.

Postgrad Med. 2008 Sep;120(3):16-26. doi: 10.3810/pgm.2008.09.1904. Review.

PMID:
18824822
[PubMed - indexed for MEDLINE]
18.

A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.

Weiss M, Hechtman L; Adult ADHD Research Group.

J Clin Psychiatry. 2006 Apr;67(4):611-9.

PMID:
16669726
[PubMed - indexed for MEDLINE]
19.

An examination of the psychometric properties of the attention deficit scales for adults with outpatient substance abusers.

West SL, Mulsow M, Arredondo R.

Am J Drug Alcohol Abuse. 2007;33(5):755-64.

PMID:
17891668
[PubMed - indexed for MEDLINE]
20.

Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders.

Bukstein OG.

Expert Rev Neurother. 2006 Apr;6(4):541-9. Review.

PMID:
16623653
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk